When will generic apixaban be available?

The date for generic apixaban (Eliquis) depends on where you are. Patent protections and regulatory approvals vary by country, and there can also be ongoing patent litigation or settlements that delay generic entry.

If you tell me your country (e.g., United States, Canada, UK, EU country, etc.), I can give a more specific update. In the meantime, you can check these sources:

- U.S. FDA Orange Book (patent and exclusivity status for apixaban/Eliquis) to see current patent listings and any 30-month stays.
- Your local health authority or pharmacy for whether a generic is currently available in your area.
- Your insurer or pharmacist for which generic manufacturers are on formulary and the expected price.

A quick note: once a generic is approved and enters the market, it’s usually bioequivalent to Eliquis and can lower cost. But switching should be done under your healthcare provider’s guidance.

If you share your country, I’ll pull together a more precise status update.